中国全科医学2024,Vol.27Issue(2) :132-137,143.DOI:10.12114/j.issn.1007-9572.2023.0230

新型冠状病毒感染脆弱人群的识别及防治展望

Identification of COVID-19 Infection in Vulnerable Population and Its Prevention and Treatment Perspectives

郑劲平 薛武军 巨春蓉 马军 曾小峰
中国全科医学2024,Vol.27Issue(2) :132-137,143.DOI:10.12114/j.issn.1007-9572.2023.0230

新型冠状病毒感染脆弱人群的识别及防治展望

Identification of COVID-19 Infection in Vulnerable Population and Its Prevention and Treatment Perspectives

郑劲平 1薛武军 2巨春蓉 1马军 3曾小峰4
扫码查看

作者信息

  • 1. 510120 广东省广州市,广州医科大学附属第一医院 国家呼吸系统疾病临床医学研究中心 国家呼吸医学中心呼吸疾病全国重点实验室 广州呼吸健康研究院
  • 2. 710061 陕西省西安市,西安交通大学第一附属医院肾脏病医院肾移植科
  • 3. 150010 黑龙江省哈尔滨市,哈尔滨血液病肿瘤研究所
  • 4. 100730 北京市,中国医学科学院北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 疑难重症及罕见病国家重点实验室 风湿免疫病学教育部重点实验室
  • 折叠

摘要

新型冠状病毒感染疫情对人类健康和全球经济造成重创.健康相关脆弱人群的免疫功能减退,导致疫苗的防护效果不足,并且,感染新型冠状病毒后重症和死亡风险更高,而目前尚缺乏足够有针对性的新型冠状病毒感染预防和治疗药物.在我国"乙类乙管"的防疫背景下,脆弱人群成为疫情防控的重点人群.因此,针对脆弱人群应该进一步优化个体免疫和防控策略,在疫苗之外,还需要补充其他预防手段,如长效中和抗体.基于此,本文将对脆弱人群的识别、免疫功能特点与预防方法进行综述,为国内健康相关脆弱人群的防治策略提供参考,期待未来可以研发出更适宜脆弱人群的预防药物,降低脆弱人群感染新型冠状病毒的风险.

Abstract

The COVID-19 pandemic has devastated human health and global economy.Diminished immune function of health-related vulnerable populations leads to insufficient protective effect of the vaccine with a higher risk of severe illness and death following infection,and there is a lack of adequate targeted drugs for the prevention and treatment of COVID-19.In the context that COVID-19 treated as a Category B disease in China,vulnerable populations have become the priority populations for epidemic prevention and control.Therefore,the strategies of individual immunization and prevention should be further optimized for vulnerable populations.In addition to vaccines,other prevention strategies should be supplemented,such as long-acting neutralizing antibodies.Based on this,this paper reviews the identification,immune function characteristics and prevention strategies of COVID-19 in vulnerable populations,to provide a reference for the prevention and control strategies for health-related vulnerable populations in China,expecting that more suitable preventive drugs for vulnerable populations can be developed in the future to reduce the risk of COVID-19 in vulnerable populations.

关键词

新型冠状病毒感染/脆弱人群/长效中和抗体/预防/综述

Key words

COVID-19/Vulnerable populations/Long-acting neutralizing antibody/Prevention/Review

引用本文复制引用

出版年

2024
中国全科医学
中国医院协会

中国全科医学

CSTPCD北大核心
影响因子:2.04
ISSN:1007-9572
参考文献量67
段落导航相关论文